Oral Propranolol in Infantile Hemangiomas: Analysis of Factors that Affect the Outcome

AIM: The primary treatment for the subset of infantile hemangiomas (IHs) which develops complication is pharmacological intervention, and propranolol has become a popular choice. Here, we evaluated the efficacy and safety of propranolol in a clinical cohort of IHs and analyzed clinical characteristi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ainipully, Arun Mohanan, Narayanan, Sarath Kumar, Vazhiyodan, Arun Preeth, Somnath, Prathap
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568152/
https://www.ncbi.nlm.nih.gov/pubmed/31258264
http://dx.doi.org/10.4103/jiaps.JIAPS_12_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568152/
https://www.ncbi.nlm.nih.gov/pubmed/31258264
http://dx.doi.org/10.4103/jiaps.JIAPS_12_18

Ejemplares similares